Aqua Bio Technology (ABTEC)

Magnus1 · januar 25, 2024, 9:18am

Går som ei kule nå de neste dagene.
Guidingen forsvarer en kurs på 12-15 kroner:moneybag:

Magnus1 · januar 30, 2024, 9:24am

Spenstig!

Magnus1 · februar 9, 2024, 10:16am

Aqua Bio Technology ASA: ABT inngår avtale om kjøp av Ovalen

8.2.2024 21:18:50 CET | Aqua Bio Technology ASA | Innsideinformasjon

Det vises til børsmeldingen fra Aqua Bio Technology ASA
(“ABT” eller “Selskapet”) den 19. desember 2023 hvor Selskapet ifm
med oppkjøpet av Cover Brands, informert om at ABT ville bli gitt en opsjon
å erverve alle aksjer i Ovalen AS (“Ovalen”). I 2022 åpnet Ovalen et flaggskip
butikk sentralt i Kristiansand i samarbeid med Cover Brands, hvor de
flaggskipbutikken kombinerer Pusterom Hudpleies tilbud av omfattende skjønnhet
opplevelser og behandlinger til forbrukere med attraktive produkttilbud.

Selskapet har i dag avtalt å kjøpe Ovalen fra Coc Invest AS, et selskap
eid av Rolf Kristian Fiala, Ørjan Djuvik Pedersen og Jesper Dønnestad Brandt
(“De ultimate eierne”) (“Oppkjøpet”) for en kjøpesum på opptil MNOK
11, hvor 5 MNOK av kjøpesummen vil være betinget av Ovalens inntekter
og EBIT i 2024 og 2025. Ovalens omsetning i 2023 vil være ca. MNOK 17 med en
positiv EBIT.

Kjøpesummen vil bli konvertert til nye aksjer (“Nye aksjer”) i ABT til a
tegningskurs 5 kroner per aksje. De nye aksjene vil være underlagt en
36 måneders lock-up forpliktelse. Gjennomføringen av oppkjøpet er betinget
etter en tilfredsstillende due diligence og en godkjenning fra ABTs styre.

Gjennomføringen av oppkjøpet forventes å gjøre ABT i stand til å bruke Ovalens
flaggskipbutikk som et «vindu» for ABT-gruppens produkter, øke salget, og
styrke ABT-gruppens merkevareprofil.

Ved gjennomføring av Oppkjøpet forventes det at ABT og Jesper
Dønnestad Brandt vil i samarbeid med de andre Ultimate Owners søke en
videre realisering av “Pusterom Hudpleie”-konseptet (
https://pusteromhudpleie.no/) som for tiden holdes av Ovalen. Hensikten er å åpne
nye flaggskipbutikker i Oslo, Bergen og Trondheim, med ABT og Cover Brands as
hovedleverandørene av produkter og nøkkeltjenester. I tillegg er det forventet
at flaggskipbutikkene vil engasjere hudpleiespesialister fra ABT og dets
datterselskaper for å gjennomføre arrangementer og tilby relevant hudpleieråd.

TekBot · mars 1, 2024, 12:54pm

Finansiell kalender

TekBot · mars 4, 2024, 11:31am

AQUA BIO TECHNOLOGY ASA - SHARE CAPITAL INCREASE REGISTERED

4.3.2024 12:29:48 CET | Aqua Bio Technology ASA | Total number of voting rights
and capital

…

Vis børsmeldingen

Reference is made to the stock exchange announcement from Aqua Bio Technology
ASA (“ABT” or the “Company”) on 12 February 2024 regarding the Company’s board
of directors resolving to issue 780,142 new shares in a subsequent offering (the
“New Shares”).

The share capital increase pertaining to the issuance of the New Shares has
today been registered with the Norwegian Registry of Business Enterprises (Nw.
Foretaksregisteret). ABT’s new share capital is NOK 140,036,552.50 divided into
56,014,621 shares, each with a nominal value of NOK 2.50.

For further information, please contact CEO Håvard Lindstrøm mobile phone +47
941 32 288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skincare products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skincare products developed by partners towards consumers and
professional users. ABT’s focus on commercialization and development of natural
ingredients and natural skincare products has been, and will continue to be, an
important part of the Company’s strategy going forward. Aqua Bio Technology is
listed on the Euronext Expand market of the Oslo Stock Exchange.

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/2956/4156/Download%20announcement
%20as%20PDF.pdf

Kilde

TekBot · mars 11, 2024, 2:18pm

Aqua Bio technology ASA - share capital increase registered

11.3.2024 15:18:15 CET | Aqua Bio Technology ASA | Total number of voting rights
and capital

…

Vis børsmeldingen

Reference is made to the stock exchange announcement from Aqua Bio Technology
ASA (“ABT” or the “Company”) on 30 January 2024 regarding the Company’s board of
directors resolving to issue 2,565,717 new shares in the Company in connection
with, inter alia, a private placement in the Company (“New Shares”). The New
Shares will be delivered on a separate ISIN pending publication of an EEA
listing prospectus approved by the Norwegian Financial Supervisory Authority.

The share capital increase pertaining to the issuance of the New Shares has
today been registered with the Norwegian Registry of Business Enterprises (Nw.
Foretaksregisteret). ABT’s new share capital is NOK 146,450,845 divided into
58,580,338 shares, each with a nominal value of NOK 2.50.

For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941
32 288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skincare products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skincare products developed by partners towards consumers and
professional users. ABT’s focus on commercialization and development of natural
ingredients and natural skincare products has been, and will continue to be, an
important part of the Company’s strategy going forward. Aqua Bio Technology is
listed on the Euronext Expand market of the Oslo Stock Exchange.

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/2964/4168/Download%20announcement
%20as%20PDF.pdf

Kilde

TekBot · april 12, 2024, 7:07am

Aqua Bio Technology ASA: Acquisition of Ovalen completed

12.4.2024 09:05:41 CEST | Aqua Bio Technology ASA | Inside information

Reference is made to Aqua Bio Technology ASA’s (“ABT” or the “Company”) stock
…

Vis børsmeldingen

exchange announcement made 8 February 2024 concerning the Company’s intended
acquisition of Ovalen AS (“Ovalen”) (the “Acquisition”). The Acquisition was
subject to a successful due diligence which was completed to ABT’s satisfaction
and ABT’s board of directors has approved the transaction which will be
completed on the terms initially agreed. Ovalen had operating revenues of NOK 17
million with an EBITA of NOK 1.1 million in 2023.

The purchase price ranges from NOK 6 million to NOK 11 million, where NOK 5
million is contingent upon future revenue and EBIT performance of the Company in
2024 and 2025. NOK 6 million of the purchase price will be settled through the
issuance of 1,200,000 consideration shares (the “Consideration Shares”) at a
subscription price of NOK 5 per Consideration Share.

The sellers of Ovalen, including its ultimate beneficial owners, have agreed to
a three-year lock-up on the Consideration Shares which will be formally issued
by ABT as soon as possible.

Ovalen owns Cover Brands AS’ (“Coverbrands”) store “Pusterom Hudpleie” which is
a physical store and beauty salon, that has received significant recognition in
Kristiansand within a short period of time. More information about “Pusterom
Hudpleie” is available at coverbrandsstore.no - https://coverbrandsstore.no/ and
pusteromhudpleie.no - https://pusteromhudpleie.no/. ABT contemplates to
establish similar stores in major cities in Norway.

Synergies

It is expected that the Acquisition will generate significant synergies for ABT,
especially benefitting our wholly owned subsidiary Coverbrands, leading to
enhanced brand building and revenue growth, more advantageous supplier
agreements and strengthened ability to successfully develop proprietary
products.

Coverbrands chairman Kristian Fiala comments:

The establishment of physical stores in Norway’s major cities will bolster
Coverbrands’ online store and its ability to successfully access the event
market. Our skilled store personnel will deliver considerable value at major
events such as Palmesus in Kristiansand, where our brand already is
well-established, and the Foma festival in Oslo, where we are proud sponsors.
Coverbrands is currently forging a strategic cooperation with a leading events
industry entity, within which the physical stores are expected to play an
instrumental role.

Rapid Strategic Scaling

Ovalen is on track with is plan to open a new store in Oslo and then aims to
quickly progress with the launch of new locations in other major cities. Upon an
expansion beyond Norway’s borders, Ovalen’s concept is expected to play a
pivotal role in the market penetration, customer loyalty, and ongoing brand
enhancement.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

This information was considered to be inside information pursuant to the EU
Market Abuse Regulation and subject to the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act. This stock exchange notice
was published by Håvard Lindstrøm, CEO, on the date and time provided.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/3020/4302/Download%20announcement
%20as%20PDF.pdf

Kilde

TekBot · april 23, 2024, 10:24am

Aqua Bio Technology ASA: Cosmed Buyout

23.4.2024 12:23:02 CEST | Aqua Bio Technology ASA | Inside information

Pursuant to the agreement Aqua Bio Technology ASA (“ABT” or the “Company”)
…

Vis børsmeldingen

entered with Varming Holding AS as seller (“Varming”) with respect to the
Company’s acquisition of all of the shares in Cosmed Beauty AS (“Cosmed”) and
Ultrabody AB on 28 June 2022 (the “Agreement”), the purchase price was agreed to
be an earn-out based on a multiple of Cosmed’s result before tax for each of the
financial years ended 2022, 2023, 2024 and 2025. The Company’s board of
directors regards such earn-out structure as suboptimal and potentially entails
a conflict of interests. As such, the Company has today entered into an
amendment agreement (“Amendment Agreement”) with Varming pursuant to which the
Company and Varming settle the remaining earn-out under the Agreement by way of
a cash payment of approximately NOK 8.3 million, to be paid by the Company
within the end of Q1 2025 and the issuance of 4,708,935 new shares ("New Shares
"), each New Share with a subscription price of NOK 8.20. The New Shares are
subject to a customary lock-up undertaking that lapses on 31 December 2025.

In connection with the execution of the Amendment Agreement, Jan Varming, who is
one of the ultimate beneficial owners of Varming, will assume the role of Chief
Financial Officer (CFO) for the ABT Group. This appointment is anticipated to
result in considerable cost savings for the ABT group by reducing the need for
external personnel and consultants. Additionally, given Mr. Varming’s extensive
experience within the Norwegian skincare industry, his role as CFO is expected
to enhance synergies 'derived from the Company’s past acquisitions, including
Ovalen AS, Cosmed Beauty AS, Ultrabody AB, Cover Brands AS, and Skinteam Norge
AS.

For further information, please contact CEO Håvard Lindstrøm mobile phone +47
941 32 288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skincare products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skincare products developed by partners towards consumers and
professional users. ABT’s focus on commercialization and development of natural
ingredients and natural skincare products has been, and will continue to be, an
important part of the Company’s strategy going forward. Aqua Bio Technology is
listed on the Euronext Expand market of the Oslo Stock Exchange.

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and subject to the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act. This stock exchange notice
was published by CEO Håvard Lindstrøm on the date and time provided.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/3054/4362/Download%20announcement
%20as%20PDF.pdf

Kilde

TekBot · april 23, 2024, 2:47pm

AQUA BIO TECHNOLOGY ASA - DISCLOSURE OF LARGE SHAREHOLDING

23.4.2024 16:47:15 CEST | Aqua Bio Technology ASA | Major shareholding
notifications

…

Vis børsmeldingen

Reference is made to the stock exchange notices from Aqua Bio Technology ASA
(the “Company” or “ABT”) on 23 April 2024 regarding the amendment agreement
(“Amendment Agreement”) the Company entered into with Varming Holding AS
(“Varming”), and the issuance of 4,708,935 new shares (the “New Shares”), each
at a subscription price of NOK 8.20 per new Share, to settle the share element
in accordance with the Amendment Agreement. The New Shares has today been
resolved by the Company’s board of directors pursuant to a board authorization
registered in the Norwegian Register of Business Enterprises on 28 September
2023. The New Shares will be delivered to a separate ISIN pending the Company’s
publication of an EEA listing prospectus approved by the Norwegian Financial
Supervisory Authority.

Following Varming’s subscription of the New Shares, Varming and close associates
will own a total of 4,976,704 shares and votes in the Company, representing
approximately 8.49% of the outstanding votes and shares in the Company, and has
thereby exceeded the 5 % threshold pursuant to section 4-2 of the Norwegian
Securities Trading Act.

This information is subject to the disclosure requirements in article 19 of the
Regulation EU 596/2014 and sections 4-2 and 5-12 of the Norwegian Securities
Trading Act.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/3056/4365/Download%20announcement
%20as%20PDF.pdf

Kilde

TekBot · april 25, 2024, 1:35pm

Aqua Bio Technology ASA: Acquisition of 3D Innovation Nordic AS and affiliated companies, together a potential major wholesale group in the Nordics

25.4.2024 15:34:41 CEST | Aqua Bio Technology ASA | Inside information

Aqua Bio Technology (“ABT” or the “Company” and together with its wholly owned
…

Vis børsmeldingen

subsidiaries, the “ABT Group”) has today, on 25 April 2024, entered into an
agreement (the “Agreement”) with CoC Invest AS (“CoC Invest”) regarding the
Company’s acquisition of all of the outstanding shares in the 3D Innovation
Nordic AS (“3D”). Pursuant to the Agreement, the Company shall further acquire
all of the outstanding shares in the companies Printprofil AS and Check Please
AS (jointly with 3D, the “Target Group”) from CoC Invest in connection with the
acquisition of 3D (jointly, the “Acquisitions”). The Target Group represents a
major wholesale group in the Nordics.

In 2023, the Target Group had an unaudited turnover of NOK 87.6 million, of
which 3D had a turnover of NOK 73 million. The Target Group companies are
profitable and EBIDTA for the Target Group in 2023 ended jointly at NOK 5
million.

The completion of the Acquisitions is subject to satisfactory due diligence and
approval from ABT’s board of directors.

Under the Agreement, the purchase price for the Acquisitions shall be settled in
a combination of shares and cash, subject to certain conditions. NOK 5 million
shares in ABT will be issued at a price of NOK 6 per share, with a 3-year lock
up. The cash will be total NOK 15 million, divided into two installments,
depending on the Target Group’s financial results. The first NOK 5 million is
triggered by an EBT of NOK 6 million in the Target Group, the next NOK 10
million when the Target Group achieves an EBT of NOK 10 million.

3D is a significant wholesale company with a market-leading sales department.
The company, which has its head office and sales department in Hønefoss, has
extensive distribution to all the major retail chains in Norway and pharmacies
in Norway and Sweden, as well as selected customers in Denmark. The company has
had considerable success in just a few years and is at the top of the Gazelle
award (Gaselle-bedrift) for 2023.

In particular, the acquisition of 3D gives ABT access to completely new
distribution channels that we do not currently have access to in both Norway and
Sweden. In interaction with ABT’s historical operations and the operations in
our existing subsidiaries, this acquisition will provide significant synergies
on several levels, says Håvard Lindstrøm, CEO of ABT.

Briefly about the companies

Check Please AS mainly sells cash register rolls and rolls for card terminals in
retail chains. The company’s founders have imported and sold cash register
rolls/rolls for bank terminals from 2002, since 2014 as Check Please. The
company has industry-leading expertise in this area. The company had an
unaudited turnover of NOK 7.6 million in 2023.

Printprofil AS is a company specialized in profiling and gift items, which is
connected to New Wave and its thousands of customers. The company had an
unaudited turnover of NOK 7 million in 2023.

Scaling

In addition to significant synergies between ABT’s historical and current
operations, the acquisition of 3D also ensures that ABT gets the opportunity to
scale its operations out of Norway to a greater extent. As of today, ABT’s
presence outside Norway is limited in Sweden, through the ownership of Ultrabody
AB.

We are far from done with Norway, but the acquisitions of 3D, Check Please and
Printprofil make ABT ready to move across national borders when the time is
right, says Lindstrøm.

Reference is made to the Cosmed buyout announcement made by the Company on 23
April 2024. Please see the attached form in accordance with article 19 of the EU
Market Abuse Regulation.

For further information, please contact CEO Håvard Lindstrøm mobile phone +47
941 32 288.

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skincare products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skincare products developed by partners towards consumers and
professional users. ABT’s focus on commercialization and development of natural
ingredients and natural skincare products has been, and will continue to be, an
important part of the Company’s strategy going forward. Aqua Bio Technology is
listed on the Euronext Expand market of the Oslo Stock Exchange.

This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and subject to the disclosure requirements pursuant to
section 5-12 of the Norwegian Securities Trading Act. This stock exchange notice
was published by CEO Håvard Lindstrøm on the date and time provided.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/3064/4384/Download%20announcement
%20as%20PDF.pdf

Notification Form - Varming Holding.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/3064/4383/Notification%20Form%20-
%20Varming%20Holding.pdf

Kilde

TekBot · april 25, 2024, 7:06pm

AQUA BIO TECHNOLOGY ASA: Q1 MARKET UPDATE AND UPDATED FINANCIAL CALENDAR

25.4.2024 21:05:54 CEST | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state

…

Vis børsmeldingen

Aqua Bio Technology ASA (“ABT”, and together with its subsidiaries, the “Group”)
has, as of the first quarter of 2024, achieved NOK 35 million in gross revenues
on a consolidated basis with a positive EBITDA. The Group subsidiary, Cover
Brands AS, was consolidated into the Group’s financial accounts from 1 January
2024. On 12 April 2024, ABT completed the acquisition of Ovalen AS, which will
be consolidated into the Group’s financial accounts with effect from 1 May 2024.
The Group’s revenues for the first quarter of 2024 has not been audited.

Considering that Q1 is typically the weakest quarter in this segment, with 60%
of annual turnover normally occurring in Q3 and Q4, ABT is on track with its
previous guidance for a turnover of NOK 140-150 million in 2024. With the
integration of Ovalen AS (www.pusteromhudpleie.no -
http://www.pusteromhudpleie.no/) starting from Q2, and assuming satisfactory due
diligence and the completion of the acquisition of 3D Innovation Nordic AS and
its affiliated companies in Q2, ABT anticipates that the turnover for 2024 will
reach NOK 200-210 million and that the pro forma turnover for 2024 for the Group
will exceed NOK 250 million.

Following ABT’s acquisition activity, the preparation of the Group’s annual
financial statements for 2023 has taken longer than anticipated. Consequently,
ABT updates its financial calendar as follows:

FINANCIAL YEAR 2023

14.06.2023 - Annual Report

FINANCIAL YEAR 2024

23.08.2024 - Half-yearly Report

28.06.2024 - Annual General Meeting

06.11.2024 - Quarterly Report - Q3

12.02.2025 - Quarterly Report - Q4

This information is published in accordance with the requirements of the
Continuing Obligations in Euronext Oslo Børs Rule Book II.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/3065/4386/Download%20announcement
%20as%20PDF.pdf

Kilde

TekBot · april 25, 2024, 7:20pm

AQUA BIO TECHNOLOGY ASA - CORRECTION: Q1 MARKET UPDATE AND UPDATED FINANCIAL CALENDAR

25.4.2024 21:18:52 CEST | Aqua Bio Technology ASA | Additional regulated
information required to be disclosed under the laws of a member state

…

Vis børsmeldingen

Aqua Bio Technology ASA (“ABT”, and together with its subsidiaries, the “Group”)
has, as of the first quarter of 2024, achieved NOK 35 million in gross revenues
on a consolidated basis with a positive EBITDA. The Group subsidiary, Cover
Brands AS, was consolidated into the Group’s financial accounts from 1 January
2024. On 12 April 2024, ABT completed the acquisition of Ovalen AS, which will
be consolidated into the Group’s financial accounts with effect from 1 May 2024.
The Group’s revenues for the first quarter of 2024 has not been audited.

Considering that Q1 is typically the weakest quarter in this segment, with 60%
of annual turnover normally occurring in Q3 and Q4, ABT is on track with its
previous guidance for a turnover of NOK 140-150 million in 2024. With the
integration of Ovalen AS (www.pusteromhudpleie.no -
http://www.pusteromhudpleie.no/) starting from Q2, and assuming satisfactory due
diligence and the completion of the acquisition of 3D Innovation Nordic AS and
its affiliated companies in Q2, ABT anticipates that the turnover for 2024 will
reach NOK 200-210 million and that the pro forma turnover for 2024 for the Group
will exceed NOK 250 million.

Following ABT’s acquisition activity, the preparation of the Group’s annual
financial statements for 2023 has taken longer than anticipated. Consequently,
ABT updates its financial calendar as follows:

FINANCIAL YEAR 2023

14.06.2024 - Annual Report

FINANCIAL YEAR 2024

23.08.2024 - Half-yearly Report

28.06.2024 - Annual General Meeting

06.11.2024 - Quarterly Report - Q3

12.02.2025 - Quarterly Report - Q4

This information is published in accordance with the requirements of the
Continuing Obligations in Euronext Oslo Børs Rule Book II.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

Håvard Lindstrøm, 004794132288, hl@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT’s cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -
https://kommunikasjon.ntb.no/ir-files/17847556/3067/4387/Download%20announcement
%20as%20PDF.pdf

Kilde

TekBot · april 25, 2024, 7:26pm

Finansiell kalender

Magnus1 · april 25, 2024, 8:03pm

Da er det bare å holde på hatten

dex1 · april 29, 2024, 5:36pm

merkelig at ikke markedet reagerer mer positivt på den sinnsyke utviklingen i selskapet , fra millioner i underskudd til positive tall og sterk vekst ?

Magnus1 · april 29, 2024, 5:53pm

Helt utrolig! Er vel nesten uunngåelig at det vil eksplodere her på et tidspunkt.

Ubruklig · april 29, 2024, 6:33pm

De har ikke lagt frem årsresultat som bekrefter det de presenterer.
REGNSKAPSÅR 2023

14.06.2024 - Årsrapport

Frem til det så stuper det ned i nye bølgedaler før resultat fremførelse bestemmer veien videre.

dex1 · april 30, 2024, 8:55am

2023 er vel uansett ikke det viktigste. Oppkjøpene påvirker vel neppe det nevneverdig… 1. Og 2 kvartal derimot… Det bør vise vei

TekBot · mai 2, 2024, 11:43am

Aqua Bio Technology ASA is placed in Penalty Bench

TekBot · mai 6, 2024, 6:30am

OSLO BØRS - STATUS COMPANIES PLACED IN RECOVERY BOX AND PENALTY BENCH

Currently the following companies are placed in Recovery Box:

SAS AB (since 03.06.2022)
…

Vis børsmeldingen

Nova Austral S.A. (since 20.06.2023)
IOG plc (since 29.09.2023)
Recreate ASA (since 20.03.2024)
Astrocast SA (Since 12.04.2024)

Recovery Box is a special compartment where Oslo Børs can place securities where the Issuer is subject to circumstances that make pricing of the securities particularly uncertain. Recovery Box is regulated in section 2.10.2 of Oslo Rule Book II (Oslo Børs and Euronext Expand) and section 3.8.2 of Euronext Growth Oslo Rule Book Part II. The relevant security will remain in the Recovery Box until the circumstances for the allocation to the Recovery Box are no longer present.

Currently the following companies are placed in Penalty Bench:

IOG plc (since 01.09.2023)
Aqua Bio Technology ASA (since 02.05.2024)
Interoil Exploration and Production ASA (since 02.05.2024)
Solis Bond Company DAC (since 02.05.2024)

Penalty Bench is a special compartment where the securities of Issuers that fail to comply with the Rules are placed.

Penalty Bench is regulated in section 2.10.3 of Oslo Rule Book II (Oslo Børs and Euronext Expand) and section 3.8.3 of Euronext Growth Oslo Rule Book Part II. Oslo Børs will remove a security from the Penalty Bench and allocate the security to the normal compartment when the issuer has corrected the violation of the Rules that was the reason for allocating the security to the Penalty Bench.

Kilde